MedTrace Logo

VitalScan MCG Rule-out Multi-centre Pivotal Study - UK

NCT02921438 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 756

Last updated 2019-04-03

No results posted yet for this study

Summary

The study is a prospective multi-centre observational study to evaluate a portable magnetocardiograph device for the rule-out of acute coronary syndrome (ACS) in patients who present to the emergency department with chest pain and other symptoms consistent with ACS.

Conditions

  • Acute Coronary Syndrome

Interventions

DEVICE

VitalScan Magnetocardiograph

A passive, non-contact, mobile medical device that measures, displays, stores, and retrieves magnetic fluctuations caused by heart activity at a patient's bedside.

Sponsors & Collaborators

  • Creavo Medical Technologies Ltd

    lead INDUSTRY

Principal Investigators

  • Steve Goodacre, MB ChB MRCP DiplMC FCEM · University of Sheffield; Sheffield, UK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-06
Primary Completion
2018-12-14
Completion
2019-02-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02921438 on ClinicalTrials.gov